GENE ONLINE|News &
Opinion
Blog

2025-09-03| Trials & Approvals

Pilatus Biosciences Advances CD36 Metabolic Checkpoint to Revolutionize Tumor Microenvironment Cancer Therapy

by Steven Chung
Share To
“Our goal is to remodel the tumor microenvironment and empower the body’s immune system to fight cancer”. Image: Dr. Raven Lin
The fight against cancer is a relentless marathon, with immunotherapy marking a transformative milestone in recent years. However, as first- and second-generation immune checkpoint inhibitors …

Pilatus Biosciences Advances CD36 Metabolic Checkpoint to Revolutionize Tumor Microenvironment Cancer Therapy Read More »

GO Prime with only $1.49 now

SUBSCRIBE NOW
LATEST
Parul Butala Appointed President of AMERCO Real Estate Company
2026-07-21
Jonathan Saunders Appointed Executive Creative Director of Kate Spade New York
2026-07-21
WDIV Opens Hybrid Newsroom and Coffee Shop in Downtown Plymouth
2026-07-21
Caesars Palace Launches 1966-Inspired Menus for 60th Anniversary Celebration
2026-07-21
Starco Brands Completes Acquisition of Custom Bakehouse
2026-07-21
FDA Grants Emergency Use Authorization for Seegene Multiplex PCR Assay Detecting Four Viruses
2026-07-21
Urologist Elizabeth Dray Finds No Basis for Linking Homeric Heroism to Modern Testosterone Screening
2026-07-21
READ MORE
EVENT
2026-08-07
Healthy Ageing Tech Show (7-9 Aug, TAIPEI WTC) (Longevity, elder care & ageing tech)
Taipei, Taiwan
2026-09-02
BIO Asia Pacific (APAC Biotech & Smart Health)
Bangkok, Thailand
2026-09-16
BIOHK (16–19, Hong Kong) (Hong Kong biotech & investment)
Hong Kong
2026-10-07
BioJapan / HealthTECH JAPAN (Biotech, Medtech, Regenerative)
Yokohama, Japan
2026-10-07
Hospital Expo Tokyo (Devices & Hospital IT)
Tokyo, Japan
2026-10-20
AusBiotech 2026 (20-23 Oct, Queensland) (Australia biotech & investment)
Queensland, Australia
SEE MORE
Scroll to Top